{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:11:19Z","timestamp":1789564279566,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.yexmp.2026.105056","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:24:24Z","timestamp":1781270664000},"page":"105056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Citalopram enhances cisplatin-induced cytotoxicity in T24 bladder cancer cells: An in vitro study"],"prefix":"10.1016","volume":"147","author":[{"given":"Pouria","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roham","family":"Deyhimfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idris","family":"Haghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolreza","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Guitynavard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Menbari Oskouie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Oliveira","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad Kazem","family":"Aghamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.yexmp.2026.105056_bb0005","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.2174\/1871520617666170327155930","article-title":"Anti-Cancer effects of citalopram on hepatocellular carcinoma cells occur via cytochrome C release and the activation of NF-kB","volume":"17","author":"Ahmadian","year":"2017","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105056_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031268","article-title":"Serotonin pathway in cancer","volume":"22","author":"Balakrishna","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1661","key":"10.1016\/j.yexmp.2026.105056_bb0015","article-title":"Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena","volume":"370","author":"Bryan","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"issue":"9","key":"10.1016\/j.yexmp.2026.105056_bb0020","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1111\/cas.15047","article-title":"The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets","volume":"112","author":"Burns","year":"2021","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105056_bb0025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.20.01665","article-title":"Radical cystectomy against Intravesical BCG for high-risk high-grade nonmuscle invasive bladder Cancer: results from the randomized controlled BRAVO-feasibility study","volume":"39","author":"Catto","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.yexmp.2026.105056_bb0030","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1364\/BOE.10.003533","article-title":"Identifying non-muscle-invasive and muscle-invasive bladder cancer based on blood serum surface-enhanced Raman spectroscopy","volume":"10","author":"Chen","year":"2019","journal-title":"Biomed. Opt. Express"},{"issue":"3","key":"10.1016\/j.yexmp.2026.105056_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030757","article-title":"Fluoxetine induces apoptosis through extrinsic\/intrinsic pathways and inhibits ERK\/NF-\u03baB-modulated anti-apoptotic and invasive potential in hepatocellular carcinoma cells in vitro","volume":"20","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105056_bb0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2005.05.039","article-title":"Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells","volume":"237","author":"Cho","year":"2006","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105056_bb0045","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/cancers11010064","article-title":"Paroxetine induces apoptosis of human breast cancer MCF-7 cells through Ca2+\u2212and p38 MAP kinase-dependent ROS generation","volume":"11","author":"Cho","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.yexmp.2026.105056_bb0050","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.yexmp.2026.105056_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114818","article-title":"SSRI antidepressant citalopram reverses the Warburg effect to inhibit hepatocellular carcinoma by directly targeting GLUT1","volume":"43","author":"Dong","year":"2024","journal-title":"Cell Rep."},{"issue":"1\u20132","key":"10.1016\/j.yexmp.2026.105056_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11010-020-03771-1","article-title":"Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure","volume":"471","author":"Elie-Caille","year":"2020","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105056_bb0065","first-page":"22","article-title":"SSRI antidepressant medications: adverse effects and tolerability","volume":"3","author":"Ferguson","year":"2001","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"52","key":"10.1016\/j.yexmp.2026.105056_bb0070","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013807","article-title":"Cisplatin-induced cardiotoxicity with midrange ejection fraction: a case report and review of the literature","volume":"97","author":"Hu","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.yexmp.2026.105056_bb0075","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/jcmm.14011","article-title":"Anticancer activity of paroxetine in human colon cancer cells: involvement of MET and ERBB3","volume":"23","author":"Jang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.yexmp.2026.105056_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030956","article-title":"The significance of matrix metalloproteinase 9 (MMP-9) and metalloproteinase 2 (MMP-2) in urinary bladder cancer","volume":"11","author":"Kudelski","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.yexmp.2026.105056_bb0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12885-016-2266-5","article-title":"Elevated ratio of MMP2\/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma","volume":"16","author":"Kunz","year":"2016","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.yexmp.2026.105056_bb0090","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1159\/000460505","article-title":"MicroRNA-218 increases the sensitivity of bladder cancer to cisplatin by targeting Glut1","volume":"41","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.yexmp.2026.105056_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100938","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"68","author":"Li","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105056_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051184","article-title":"The association between selective serotonin reuptake inhibitors (SSRIs) use and the risk of bladder Cancer: a Nationwide population-based cohort study","volume":"12","author":"Liu","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.yexmp.2026.105056_bb0105","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur. Urol. Oncol."},{"issue":"12","key":"10.1016\/j.yexmp.2026.105056_bb0110","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/jcmm.17783","article-title":"Quercetin can be a more reliable treatment for metastatic prostate cancer than the localized disease: an in vitro study","volume":"27","author":"Mirzaei","year":"2023","journal-title":"J. Cell. Mol. Med."},{"issue":"8","key":"10.1016\/j.yexmp.2026.105056_bb0115","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3109\/0284186X.2010.509109","article-title":"Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival","volume":"49","author":"Offersen","year":"2010","journal-title":"Acta Oncol."},{"issue":"9","key":"10.1016\/j.yexmp.2026.105056_bb0120","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexmp.2026.105056_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.912699","article-title":"Neoadjuvant treatment in muscle-invasive bladder cancer: from the beginning to the latest developments","volume":"12","author":"Roviello","year":"2022","journal-title":"Front. Oncol."},{"issue":"26","key":"10.1016\/j.yexmp.2026.105056_bb0130","doi-asserted-by":"crossref","first-page":"42789","DOI":"10.18632\/oncotarget.17050","article-title":"Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation","volume":"8","author":"Sakka","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.yexmp.2026.105056_bb0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12032-024-02338-0","article-title":"Citalopram, an antipsychotic agent, induces G1\/G0 phase cell cycle arrest and promotes apoptosis in human laryngeal carcinoma HEP-2 cells","volume":"41","author":"Salama","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.yexmp.2026.105056_bb0140","first-page":"1","article-title":"Induction of DNA damage and growth arrest by citalopram in breast cancer cells mediated via activation of Gadd45a and apoptotic genes","author":"Salama","year":"2025","journal-title":"Ultrastruct. Pathol."},{"issue":"4","key":"10.1016\/j.yexmp.2026.105056_bb0145","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00428-018-2310-8","article-title":"Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study","volume":"472","author":"Santi","year":"2018","journal-title":"Virchows Arch."},{"key":"10.1016\/j.yexmp.2026.105056_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.111079","article-title":"Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents","volume":"136","author":"Santos","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105056_bb0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1566524015666150114113411","article-title":"Serotonin and cancer: what is the link?","volume":"15","author":"Sarrouilhe","year":"2015","journal-title":"Curr. Mol. Med."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105056_bb0160","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/cas.13995","article-title":"Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer","volume":"110","author":"Sawayama","year":"2019","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.yexmp.2026.105056_bb0165","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1182\/blood-2002-07-2044","article-title":"Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells","volume":"101","author":"Serafeim","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.yexmp.2026.105056_bb0170","first-page":"485","article-title":"Risk factors for bladder Cancer: results of a survey of hospital patients","volume":"9","author":"Shadab","year":"2023","journal-title":"J. Cancer Allied Spec."},{"key":"10.1016\/j.yexmp.2026.105056_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.904701","article-title":"Antidepressants fluoxetine mediates endoplasmic reticulum stress and autophagy of non-small cell lung Cancer cells through the ATF4-AKT-mTOR signaling pathway","volume":"13","author":"Shao","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105056_bb0180","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1464-410X.2006.06056.x","article-title":"The effect of serotonin and serotonin antagonists on bladder cancer cell proliferation","volume":"97","author":"Siddiqui","year":"2006","journal-title":"BJU Int."},{"issue":"3b","key":"10.1016\/j.yexmp.2026.105056_bb0185","first-page":"1757","article-title":"Matrix metalloproteinase-9 (MMP-9) immunoreactive protein in urinary bladder cancer: a marker of favorable prognosis","volume":"28","author":"Vasala","year":"2008","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.yexmp.2026.105056_bb0190","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/cncr.10876","article-title":"Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma","volume":"95","author":"Vaskivuo","year":"2002","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.yexmp.2026.105056_bb0195","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7785\/tcrt.2012.500343","article-title":"Inhibition of glucose transporter 1 (GLUT1) chemosensitized head and neck cancer cells to cisplatin","volume":"12","author":"Wang","year":"2013","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.yexmp.2026.105056_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.879748","article-title":"The combination of a novel GLUT1 inhibitor and cisplatin synergistically inhibits breast Cancer cell growth by enhancing the DNA damaging effect and modulating the Akt\/mTOR and MAPK signaling pathways","volume":"13","author":"Weng","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexmp.2026.105056_bb0205","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.2147\/OTT.S219111","article-title":"Communication of cancer cells and lymphatic vessels in cancer: focus on bladder cancer","volume":"12","author":"Wu","year":"2019","journal-title":"Onco. Targets Ther."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105056_bb0210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.hbpd.2024.09.010","article-title":"Cisplatin induces acute liver injury by triggering caspase-3\/GSDME-mediated cell pyroptosis","volume":"24","author":"Wu","year":"2024","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.yexmp.2026.105056_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114962","article-title":"Fluoxetine inactivates STAT3\/NF-\u03baB signaling and promotes sensitivity to cisplatin in bladder cancer","volume":"164","author":"Yang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105056_bb0220","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.yexmp.2026.105056_bb0225","article-title":"CNN1 represses bladder Cancer progression and metabolic reprogramming by modulating HIF-1\u03b1 signaling pathway","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexmp.2026.105056_bb0230","doi-asserted-by":"crossref","first-page":"04109","DOI":"10.7189\/jogh.13.04109","article-title":"The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040","volume":"13","author":"Zhang","year":"2023","journal-title":"J. Glob. Health"},{"issue":"2","key":"10.1016\/j.yexmp.2026.105056_bb0235","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.3892\/mmr.2015.3684","article-title":"VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin","volume":"12","author":"Zhu","year":"2015","journal-title":"Mol. Med. Rep."}],"updated-by":[{"DOI":"10.1016\/j.yexmp.2026.105074","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000}}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:52:23Z","timestamp":1789563143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480026000353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"alternative-id":["S0014480026000353"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105056","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Citalopram enhances cisplatin-induced cytotoxicity in T24 bladder cancer cells: An in vitro study","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105056"}}